Results 41 to 50 of about 67,047,750 (221)

Heart failure with mid-range ejection fraction: Current evidence and uncertainties

open access: yesMonaldi Archives for Chest Disease, 2019
Heart failure (HF) with mid-range ejection fraction (HFmrEF) has been conceptualized by the European Society of Cardiology guidelines with the aim of stimulating research to fill a gap in knowledge: whether such a condition exists as a distinct ...
Raffaele Martone   +2 more
doaj   +1 more source

Beta-blockers are associated with reverse remodeling in patients with dilated cardiomyopathy and mid-range ejection fraction

open access: yesAmerican Heart Journal Plus, 2021
Background: Beta-blockers have been shown to induce left ventricular reverse remodeling (LVRR) in heart failure with reduced ejection fraction. This study aimed to determine whether beta-blockers could induce LVRR in patients with heart failure with mid ...
Nobuyuki Enzan   +6 more
doaj   +1 more source

Stress Testing in Heart Failure with Preserved Ejection Fraction

open access: yes, 2021
Exertional dyspnea is the most common symptom in patients with heart failure with preserved ejection fraction; however, it is not specific to this disease.
심지영
core   +1 more source

Association Between Arterial Stiffness and Heart Failure With Preserved Ejection Fraction

open access: yesFrontiers in Cardiovascular Medicine, 2021
Cardiovascular diseases are the leading cause of mortality in the world. Heart failure with preserved ejection fraction (HFpEF) accounts for about half of all heart failure.
Chen Chi, Yifan Liu, Yawei Xu, Dachun Xu
doaj   +1 more source

Insights Into Myocardial Oxygenation and Cardiovascular Magnetic Resonance Tissue Biomarkers in Heart Failure With Preserved Ejection Fraction. [PDF]

open access: yes, 2022
BACKGROUND The pathophysiology of heart failure with preserved ejection fraction is not well understood, but evidence strongly suggests involvement of microvascular dysfunction.
Jung, Bernd   +7 more
core   +1 more source

The clinical characteristics of acute heart failure patients with mid-range ejection fraction in Turkey: A subgroup analysis from journey HF-TR study

open access: yesInternational Journal of the Cardiovascular Academy, 2020
Background: Heart failure (HF) is a clinical syndrome characterized with a wide spectrum of left ventricular (LV) structural and functional abnormalities.
Umit Yasar Sinan   +8 more
doaj   +1 more source

Approach to the Treatment of Heart Failure With Preserved Ejection Fraction and Mid- Range Ejection Fraction [PDF]

open access: yes, 2017
In this article we discuss the treatment of heart failure (HF) with preserved ejection fraction (HFpEF) and of HF with mid-range ejection fraction (HFmrEF) as has received considerable interest since the publciation of the 2016 European Society of ...
Andrew JS Coats   +2 more
core   +1 more source

Position of Patients with Mid-Range Ejection Fraction in the General Chronic Heart Failure Population

open access: yesАрхивъ внутренней медицины, 2021
The European society of cardiology guideline for the diagnosis and treatment of acute and chronic heart failure (CHF) in 2016 identified a new group of patients with mid-range left ventricular ejection fraction (LVEF) with reference interval in the range
N. T. Vatutin   +2 more
doaj   +1 more source

Atmospheric Water Harvesting Through Polymer Hydrogel Sorbents: Materials Chemistry, Design Strategies, and Applications

open access: yesAdvanced Science, EarlyView.
Polymer‐based hydrogels have emerged as promising materials for atmospheric water harvesting (AWH) due to their high water affinity, tunable network structure, and excellent moisture adsorption‐desorption performance. Functional hydrogel systems enable efficient water capture and controlled release under low‐energy conditions, offering a sustainable ...
Swagata Datta   +6 more
wiley   +1 more source

Pharmacological management of heart failure with reduced ejection fraction

open access: yes, 2022
Heart failure with reduced ejection fraction is a disease with a high prevalence, cost, and mortality rate. However, in recent years, new diagnostic and management breakthroughs have been made, as well as new pharmacological and non-pharmacological ...
Oladunjoye, Kayode
core  

Home - About - Disclaimer - Privacy